how does semaglutide reduce cardiovascular risk New Science Suggests Improves CV Outcomes Beyond Weight Loss Semaglutide in Cardiometabolic Diseases: SELECTing

Persistence at 360 days was significantly higher for semaglutide QW (67.0%) versus dulaglutide (56.0%), liraglutide (40.4%), and exenatide QW (35.5%)

The complexity of neural circuits that control food intake and energy balance in the hypothalamic nuclei explains some of the constraints involved in the prevention and treatment of obesity

Kidney stones are a painful problem that can be largely prevented through diet and lifestyle changes....

In conditions such as Alzheimers disease (AD), Parkinsons disease (PD), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Huntingtons disease (HD), and Lewy body dementia (LBD), dysregulated glial activity, marked by sustained microglial and astrocytic activation, initiates a cascade of cytokine release, oxidative stress, and impaired neuronal support

Trulicity is a prescription medication used to treat type 2 diabetes. It is in the class of drugs called GLP-1 receptor agonists and works by stimulating the release of insulin and decreasing the production of sugar by the liver. The pre-filled pens come in a pack of 4 and contain a solution of dulaglutide, the active ingredient, in a concentration of 1.5 mg per 0.5 mL. These pens are used to inject Trulicity subcutaneously (under the skin) once a week and are intended for single-use only. They are convenient and easy to use, allowing patients to self-administer their medication at home